|
Philom Bios Inc. |
|
Novozymes Biologicals Holding A/S (“Novozymes”), a wholly-owned subsidiary of Novozymes A/S, has made an all-cash Offer to acquire all of the issued and outstanding shares of Philom Bios by way of a take-over bid. The documents related to this bid: 'Bid Circular', the 'Letter of Transmittal' and the 'Notice of Guaranteed Delivery' can be downloaded and viewed in the PDF documents below. Bid Circular The Board of Directors of Philom Bios Inc.UNANIMOUSLY RECOMMENDS that Philom Bios Inc. shareholders ACCEPT the Offer and TENDER their common shares to the Offer. For more information see the Directors Circular which can be downloaded and viewed in the PDF document below. Directors Circular Shareholder ServicesCIBC Mellon Trust Company serves as Philom Bios' transfer agent and registrar. Shares held in Own Name: CIBC Mellon Trust Company Shares held by Intermediary: How to Buy or Sell Shares of Philom BiosPhilom Bios shares are not listed on a stock exchange. However, our shares are freely tradable in most provinces of Canada, not subject to any resale restrictions, other than that the shares must be sold through a registered securities broker (or, alternatively, using exemptions in securities legislation from the requirement to use a broker). Philom Bios shares can be purchased or sold in an over-the-counter (OTC) market. For more information on buying or selling Philom Bios shares, please contact your investment advisor or Philom Bios' Chief Financial Officer. Legal DisclaimerShareholders are cautioned to consult their own investment advisors before engaging in any trade of their Philom Bios shares to ensure it is a suitable investment and also to ensure compliance with securities and any other applicable legislative requirement respecting such trade.
|
|